Adjuvant vs Surgery Only in Early-stage Recurrent NPC
Adjuvant Therapy Versus Endoscopic Surgery Alone in Early-stage Recurrent Nasopharyngeal Carcinoma: A Multicenter Randomized Controlled Trial
Trial Details
- NCT ID
- NCT06228079
- Phase
- PHASE3
- Sponsor
- Eye & ENT Hospital of Fudan University
- Status
- RECRUITING
- Cancer Type
- Head and Neck Cancer
- Interventions
- Immunotherapy,Toripalimab Injection
- Chemotherapy,Gemcitabine based regimen
- Locations (sample)
- Shanghai, Shanghai Municipality, China|31.22222,121.45806
- Fuzhou, China|26.06139,119.30611
- Nanning, China|22.81667,108.31667
- Shanghai, China|31.22222,121.45806
- Shanghai, China|31.22222,121.45806
Key Eligibility Criteria
- Pathologically diagnosed with recurrent nasopharyngeal carcinoma;
- Stage rT1 or rT2(superficial parapharyngeal space, distance to internal carotid artery \>5mm)or rT3 (confined to the bottom wall of the sphenoid si…
- Cervical lymph node metastasis can be controlled locally
- Age 18 to 75 years;
For full eligibility, visit ClinicalTrials.gov.